Provided by Tiger Fintech (Singapore) Pte. Ltd.

CSTONE PHARMA-B

3.570
+0.000
Volume:9.37M
Turnover:34.45M
Market Cap:4.58B
PE:-11.45
High:3.770
Open:3.600
Low:3.550
Close:3.570
Loading ...

CStone Pharmaceuticals Submit Clinical Trial Application in Australia for Cancer Drug

MT Newswires Live
·
6 hours ago

CStone Submits Clinical Trial Application in Australia for Cs5001 (Ror1 ADC) in Combination With First-Line Standard-of-Care for Dlbcl

THOMSON REUTERS
·
13 hours ago

CStone Pharmaceuticals Carries Out First Dosing in Multi-Cancer Drug Trial

MT Newswires Live
·
04 Mar

CStone Announces First Patient Dosed in Global Multicenter Phase I Clinical Trial of Cs2009, a Pd-1/Vegf/Ctla-4 Trispecific Antibody

THOMSON REUTERS
·
04 Mar

There's No Escaping CStone Pharmaceuticals' (HKG:2616) Muted Revenues Despite A 28% Share Price Rise

Simply Wall St.
·
15 Feb

CStone Pharmaceuticals' Lung Cancer Drug Included in ESMO Living Guideline

MT Newswires Live
·
10 Feb

CStone Announces Inclusion of Cejemly® (Sugemalimab) as a First-Line Combination Therapy for Nsclc in Esmo Guideline

THOMSON REUTERS
·
10 Feb

CStone Pharmaceuticals - Announces Inclusion of Sugemalimab (Cejemly®) as First-Line Combination Therapy for Nsclc

THOMSON REUTERS
·
10 Feb

CStone Pharmaceuticals Partners Up with Latin American Pharmaceutical Firm

MT Newswires Live
·
03 Feb

CStone Pharmaceuticals - CStone and Steincares Enter Into Partnership to Market Sugemalimab in Latin America

THOMSON REUTERS
·
27 Jan

CStone Pharmaceuticals Submits Application for Solid Tumor Drug Trials in Australia

MT Newswires Live
·
23 Dec 2024

CStone Announces Submission of Clinical Trial Application in Australia for Cs2009, an Innovative Pd-1/Vegf/Ctla-4 Trispecific Antibody

THOMSON REUTERS
·
23 Dec 2024

CStone Pharmaceuticals Enrolls First Patient in Phase 1B Trial for Anti-Tumor Drug

MT Newswires Live
·
19 Dec 2024

Is CStone Pharmaceuticals (HKG:2616) Weighed On By Its Debt Load?

Simply Wall St.
·
12 Dec 2024

CStone Pharmaceuticals Grants Commercial Rights of Tumor Drug for MENA Region to UAE Firm

MT Newswires Live
·
21 Nov 2024

BRIEF-Cstone Pharmaceuticals & Pharmalink Enter Into Strategic Partnership For Sugemalimab

Reuters
·
21 Nov 2024